WESLEY R ELINGBURG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WESLEY R ELINGBURG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WESLEY R ELINGBURG. WESLEY R ELINGBURG is EVP & Chief Financial Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Latest Insider Trading Transactions of WESLEY R ELINGBURG
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 39.00 | 17,500 | 682,500 | 87,500 | |
May 06 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 17,500 | 875,000 | 56,244 | 73.7 K to 56.2 K (-23.73 %) |
May 06 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 39.00 | 17,500 | 682,500 | 73,744 | 56.2 K to 73.7 K (+31.11 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.70 | 942 | 43,049 | 56,244 | 57.2 K to 56.2 K (-1.65 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.72 | 889 | 40,645 | 57,186 | 58.1 K to 57.2 K (-1.53 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.73 | 262 | 11,981 | 58,075 | 58.3 K to 58.1 K (-0.45 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.77 | 392 | 17,942 | 58,337 | 58.7 K to 58.3 K (-0.67 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.78 | 262 | 11,994 | 58,729 | 59 K to 58.7 K (-0.44 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.80 | 6,492 | 297,334 | 58,991 | 65.5 K to 59 K (-9.91 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.81 | 915 | 41,916 | 65,483 | 66.4 K to 65.5 K (-1.38 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.82 | 523 | 23,964 | 66,398 | 66.9 K to 66.4 K (-0.78 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.83 | 78 | 3,575 | 66,921 | 67 K to 66.9 K (-0.12 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.85 | 1,360 | 62,356 | 66,999 | 68.4 K to 67 K (-1.99 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.86 | 314 | 14,400 | 68,359 | 68.7 K to 68.4 K (-0.46 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.90 | 1,308 | 60,037 | 68,673 | 70 K to 68.7 K (-1.87 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.91 | 157 | 7,208 | 69,981 | 70.1 K to 70 K (-0.22 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.92 | 105 | 4,822 | 70,138 | 70.2 K to 70.1 K (-0.15 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.95 | 758 | 34,830 | 70,243 | 71 K to 70.2 K (-1.07 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.00 | 2,014 | 92,644 | 71,001 | 73 K to 71 K (-2.76 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.01 | 445 | 20,474 | 73,015 | 73.5 K to 73 K (-0.61 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.02 | 26 | 1,197 | 73,460 | 73.5 K to 73.5 K (-0.04 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.05 | 942 | 43,379 | 73,486 | 74.4 K to 73.5 K (-1.27 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.06 | 288 | 13,265 | 74,428 | 74.7 K to 74.4 K (-0.39 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.18 | 915 | 42,255 | 74,716 | 75.6 K to 74.7 K (-1.21 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.20 | 4,786 | 221,113 | 75,631 | 80.4 K to 75.6 K (-5.95 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.21 | 602 | 27,818 | 80,417 | 81 K to 80.4 K (-0.74 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.22 | 52 | 2,403 | 81,019 | 81.1 K to 81 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.23 | 78 | 3,606 | 81,071 | 81.1 K to 81.1 K (-0.10 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.24 | 52 | 2,404 | 81,149 | 81.2 K to 81.1 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.25 | 183 | 8,464 | 81,201 | 81.4 K to 81.2 K (-0.22 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.26 | 78 | 3,608 | 81,384 | 81.5 K to 81.4 K (-0.10 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.27 | 52 | 2,406 | 81,462 | 81.5 K to 81.5 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.28 | 52 | 2,407 | 81,514 | 81.6 K to 81.5 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.29 | 78 | 3,611 | 81,566 | 81.6 K to 81.6 K (-0.10 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.30 | 105 | 4,862 | 81,644 | 81.7 K to 81.6 K (-0.13 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.31 | 288 | 13,337 | 81,749 | 82 K to 81.7 K (-0.35 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.32 | 183 | 8,477 | 82,037 | 82.2 K to 82 K (-0.22 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.34 | 105 | 4,866 | 82,220 | 82.3 K to 82.2 K (-0.13 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.35 | 52 | 2,410 | 82,325 | 82.4 K to 82.3 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.38 | 52 | 2,412 | 82,377 | 82.4 K to 82.4 K (-0.06 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.40 | 314 | 14,570 | 82,429 | 82.7 K to 82.4 K (-0.38 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.41 | 131 | 6,080 | 82,743 | 82.9 K to 82.7 K (-0.16 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.42 | 26 | 1,207 | 82,874 | 82.9 K to 82.9 K (-0.03 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 46.43 | 446 | 20,708 | 82,900 | 83.3 K to 82.9 K (-0.54 %) |
Mar 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Payment of Exercise | F | 46.60 | 19,992 | 931,627 | 83,346 | 103.3 K to 83.3 K (-19.35 %) |
Mar 03 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | A | 47.89 | 15,000 | 718,350 | 15,000 | |
Mar 03 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Grant | A | 0.00 | 4,000 | 0 | 103,338 | 99.3 K to 103.3 K (+4.03 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 24.46 | 35,000 | 856,100 | 35,000 | |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.25 | 2,006 | 96,790 | 99,338 | 101.3 K to 99.3 K (-1.98 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.30 | 1,246 | 60,182 | 101,344 | 102.6 K to 101.3 K (-1.21 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.31 | 1,794 | 86,668 | 102,590 | 104.4 K to 102.6 K (-1.72 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.35 | 7,144 | 345,412 | 104,384 | 111.5 K to 104.4 K (-6.41 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.36 | 1,520 | 73,507 | 111,528 | 113 K to 111.5 K (-1.34 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.38 | 4,134 | 200,003 | 113,048 | 117.2 K to 113 K (-3.53 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.39 | 730 | 35,325 | 117,182 | 117.9 K to 117.2 K (-0.62 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.40 | 5,502 | 266,297 | 117,912 | 123.4 K to 117.9 K (-4.46 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.41 | 730 | 35,339 | 123,414 | 124.1 K to 123.4 K (-0.59 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.42 | 639 | 30,940 | 124,144 | 124.8 K to 124.1 K (-0.51 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.45 | 121 | 5,862 | 124,783 | 124.9 K to 124.8 K (-0.10 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.47 | 4,955 | 240,169 | 124,904 | 129.9 K to 124.9 K (-3.82 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.49 | 790 | 38,307 | 129,859 | 130.6 K to 129.9 K (-0.60 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.50 | 3,081 | 149,429 | 130,649 | 133.7 K to 130.6 K (-2.30 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 48.55 | 608 | 29,518 | 133,730 | 134.3 K to 133.7 K (-0.45 %) |
Feb 24 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 24.46 | 35,000 | 856,100 | 134,338 | 99.3 K to 134.3 K (+35.23 %) |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 39.34 | 11,937 | 469,602 | 41,000 | |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 15,556 | 514,320 | 0 | |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 27,107 | 1,355,350 | 99,338 | 126.4 K to 99.3 K (-21.44 %) |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 15,556 | 514,320 | 126,445 | 110.9 K to 126.4 K (+14.03 %) |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.01 | 386 | 19,304 | 110,889 | 111.3 K to 110.9 K (-0.35 %) |
Feb 17 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 39.34 | 11,937 | 469,602 | 111,275 | 99.3 K to 111.3 K (+12.02 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 39.34 | 5,997 | 235,922 | 52,937 | |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 5,997 | 299,850 | 99,233 | 105.2 K to 99.2 K (-5.70 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 39.34 | 5,997 | 235,922 | 105,230 | 99.2 K to 105.2 K (+6.04 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 39.34 | 6,666 | 262,240 | 58,934 | |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 4,375 | 144,648 | 15,556 | |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 8,857 | 442,850 | 99,233 | 108.1 K to 99.2 K (-8.19 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.01 | 31 | 1,550 | 108,090 | 108.1 K to 108.1 K (-0.03 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.02 | 1,815 | 90,786 | 108,121 | 109.9 K to 108.1 K (-1.65 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.03 | 338 | 16,910 | 109,936 | 110.3 K to 109.9 K (-0.31 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 39.34 | 6,666 | 262,240 | 110,274 | 103.6 K to 110.3 K (+6.43 %) |
Jan 04 2005 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 4,375 | 144,648 | 103,608 | 99.2 K to 103.6 K (+4.41 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 8,057 | 266,385 | 19,931 | |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 8,057 | 402,850 | 99,233 | 107.3 K to 99.2 K (-7.51 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 8,057 | 266,385 | 107,290 | 99.2 K to 107.3 K (+8.12 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 39.34 | 8,200 | 322,588 | 65,600 | |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 3,125 | 103,320 | 27,988 | |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 8,200 | 410,000 | 99,233 | 107.4 K to 99.2 K (-7.63 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 50.00 | 3,125 | 156,250 | 107,433 | 110.6 K to 107.4 K (-2.83 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 39.34 | 8,200 | 322,588 | 110,558 | 102.4 K to 110.6 K (+8.01 %) |
Dec 30 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 3,125 | 103,320 | 102,358 | 99.2 K to 102.4 K (+3.15 %) |
Nov 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 15,555 | 514,287 | 31,113 | |
Nov 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 47.50 | 15,555 | 738,863 | 99,233 | 114.8 K to 99.2 K (-13.55 %) |
Nov 24 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 15,555 | 514,287 | 114,788 | 99.2 K to 114.8 K (+15.68 %) |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Option Exercise | M | 33.06 | 77,776 | 2,571,469 | 46,668 | |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.00 | 44,869 | 2,019,105 | 99,233 | 144.1 K to 99.2 K (-31.14 %) |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.25 | 8,513 | 385,213 | 144,102 | 152.6 K to 144.1 K (-5.58 %) |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.35 | 5,489 | 248,926 | 152,615 | 158.1 K to 152.6 K (-3.47 %) |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Sell | S | 45.40 | 18,905 | 858,287 | 158,104 | 177 K to 158.1 K (-10.68 %) |
Oct 28 2004 | LH | LABORATORY CORP OF ... | ELINGBURG WESLEY R | EVP & Chief Financi ... | Buy | M | 33.06 | 77,776 | 2,571,469 | 177,009 | 99.2 K to 177 K (+78.38 %) |
Page: 1